Renal Business Today

Epogen

Billing Solutions: Billing Self-Administered Epogen/ESA's

I understand we are supposed to bill self-administered Epogen for Medicare home dialysis patients, according to the medication schedule prescribed by the patient’s physician. However, some of the physicians only specify the number of times per week the patient is supposed ...More
March 12, 2013
Posted in Articles, Practice Management
Amgen Releases 2012 Revenue

THOUSAND OAKS, Calif.—Amgen announced financial results for the fourth quarter and full year of 2012. ...More
January 24, 2013
Posted in News, Business
CNN: DaVita Whistleblowers Hire Private Attorneys

DENVER—Two DaVita whistleblowers who alleged the dialysis provider intentionally threw away extra medication to boost reimbursement have hired private attorneys to bring the case to trial in 2013, according to CNN. ...More
November 30, 2012
Posted in News, Government & Regulation
Department of Justice Drops DaVita Inquiry

DENVER— DaVita announced that the United States Attorney's Office (USAO) for St. Louis recently informed the company that the USAO completed its investigation and is not taking any action against the company. ...More
October 2, 2012
Posted in News, Government & Regulation
DaVita Announces Woodard Qui Tam Settlement

DENVER—DaVita announced that it has reached an agreement in principle to settle all claims arising out of the previously disclosed litigation filed in 2002 in the U.S. District Court in the Eastern District of Texas. ...More
July 3, 2012
Posted in News, Business
New Anemia Drug, New Opportunity

How Affymax Inc., and Takeda Pharmaceuticals U.S.A. plan to give patients other alternatives to manage anemia. ...More
June 15, 2012
Posted in Articles, Clinical & Pharma, Government & Regulation
Amgen Gets Supreme Court Review of Stock Fraud Lawsuit

WASHINGTON—The U.S. Supreme Court will decide whether investors must prove that misinformation from Amgen Inc. propped up its stock price before they can pursue a class-action stock-fraud suit against the world’s largest biotechnology company. ...More
June 14, 2012
Posted in News, Government & Regulation
FDA Panel Votes in Favor of Affymax Anemia Drug

A federal panel has voted 15-1 in favor of recommending the FDA approval of Affymax's anemia drug peginesatide, according to a Dec. 7 report from the San Francisco Business Times. ...More
December 7, 2011
Posted in Blog, Clinical & Pharma, Government & Regulation
Amgen, DaVita Ink Epogen Deal Through 2018

THOUSAND OAKS, Calif.—DaVita signed on Nov. 15 a supply agreement with Amgen under which Epogen will account for at least 90 percent of the dialysis provider's anemia drug requirements through 2018, according to a Nov. 18 regulatory filing from Amgen. ...More
November 21, 2011
Posted in News, Business
ESRD Population Grows, EPO Use Decreases

The latest numbers from the U.S. Renal Data System (USRDS) have been released and they show an every-growing patient population and downward trend in the use of erythropoietin-stimulating agents (ESAs) ...More
October 19, 2011
Posted in Blog, Government & Regulation